However, for clinical purposes, it may be of use to use polySia-NCAM antibodies in immunohistochemical stainings of astrocytomas, since positive staining very likely rules out the possiblity of pilocytic astrocytomas. Here, NCAM1 is linked to astrocytoma (excluding glioblastoma).